As a major natural component of the extracellular matrix (ECM),
hyaluronic acid (HA) is an excellent choice for biomimetic, biocompatible
therapeutic materials. Furthermore, thiol-modified forms of HA are capable of
forming macroporous hydrogels that allow for both controlled cytokine release and
extensive vessel in-growth. It has previously been shown that...
Biocompatible hydrogels composed of covalently crosslinked, chemically modified hyaluronan (HA), gelatin (Gtn), and heparin (Hp) were synthesized for controlled release of human vascular endothelial growth factor (VEGF) or basic fibroblast growth factor (bFGF). We hypothesized that inclusion of small quantities of heparin in these gels would result in regulated growth...